Study Suggests MMR Vaccine May Be Linked with Fewer Deaths from COVID-19
Epidemiological data suggests populations with the highest measles-mumps-rubella (MMR) vaccination rates often have the fewest deaths from COVID-19.
The Critical Need for Vaccines and Higher Vaccine-Compliance Rates
Vaccines have historically eradicated deadly diseases, but a resistance among patients is a growing concern for public health.
In the Shadow of COVID-19, Will Other Vaccine Development Programs Be Left Behind?
As governments around the world ramp up COVID-19 prevention activities, are other diseases of international importance and their prevention programs suddenly on pause?
CDC Analyses Show Flu Vaccine Reduces Risk of Hospitalization in Children and Death in Adults
Two analyses by the Centers for Disease Control and Prevention (CDC) show the influenza (flu) vaccine can reduce the likelihood of hospitalization in children and death in adults.
Trivalent HBV Vaccine Superior in Efficacy in Adults 45 Years and Older
A Phase III study has found a trivalent hepatitis B virus (HBV) vaccine demonstrated superiority in adults 45 years and older and noninferior in adults older than 18 years compared with a monovalent vaccine.
Flu Vaccine May Reduce Risk of Heart Attack and Stroke in Hypertensive Individuals
A new study shows cardiovascular outcomes may improve in individuals with hypertension if they receive the influenza (flu) vaccine during the flu season.
Skin Patch Shows Promise for Delivery of Influenza Vaccine
Researchers at the University of Rochester Medical Center in New York City have developed a new type of skin patch that could replace needles as a method to deliver the influenza (flu) vaccine.
NIAID Awards $30 Million to Develop Tuberculosis Vaccine
The awards establish and provide up to seven years of support for three Immune Mechanisms of Protection Against Mycobacterium Tuberculosis (IMPAc-TB) Centers to elucidate the immune responses needed to protect against Mtb infection.
NIH to Evaluate Experimental Adjuvants for Seasonal Influenza Vaccine
The National Institutes of Health (NIH) is conducting an early-stage clinical trial to evaluate the safety and efficacy of two licensed seasonal influenza vaccines administered with or without novel adjuvants.
HPV Vaccine Exceeds Expectations by Providing Herd Immunity
A new study shows the HPV vaccine is far more effective than expected, with benefits extending beyond those who receive the vaccine.
